Biotage AB (publ)

OM:BIOT 주식 보고서

시가총액: SEK 12.7b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biotage 관리

관리 기준 확인 3/4

Biotage's CEO는 Torben Jorgensen, Jan2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 SEK 52.58M 가치에 해당하는 회사 주식의 0.4% 직접 소유합니다. 52.58M. 경영진과 이사회의 평균 재임 기간은 각각 3.4 년과 2.5 년입니다.

주요 정보

Torben Jorgensen

최고 경영자

SEK 857.0k

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권0.4%
경영진 평균 재임 기간3.5yrs
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Jun 08
Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

May 21
Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Apr 28
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Mar 04
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Feb 22
Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Feb 21
Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 18
Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Feb 08
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

Jan 07
Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Dec 08
At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Oct 27
Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Jul 12
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Jun 08
An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

May 24
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 05
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Mar 12
These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 21
Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Jan 06
Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Dec 03
Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Oct 27
Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Oct 07
Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Biotage (STO:BIOT) Could Easily Take On More Debt

Sep 03
Biotage (STO:BIOT) Could Easily Take On More Debt

Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

Jul 10
Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jun 25
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

May 28
Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 23
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Mar 29
Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Mar 14
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 28
Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Feb 13
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jan 23
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Is Biotage (STO:BIOT) A Risky Investment?

Dec 10
Is Biotage (STO:BIOT) A Risky Investment?

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Nov 03
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

CEO 보상 분석

Torben Jorgensen 의 보수는 Biotage 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

SEK 236m

Dec 31 2023SEK 857kn/a

SEK 246m

Sep 30 2023n/an/a

SEK 189m

Jun 30 2023n/an/a

SEK 216m

Mar 31 2023n/an/a

SEK 240m

Dec 31 2022SEK 817kn/a

SEK 268m

Sep 30 2022n/an/a

SEK 240m

Jun 30 2022n/an/a

SEK 228m

Mar 31 2022n/an/a

SEK 216m

Dec 31 2021SEK 732kn/a

SEK 205m

Sep 30 2021n/an/a

SEK 203m

Jun 30 2021n/an/a

SEK 187m

Mar 31 2021n/an/a

SEK 174m

Dec 31 2020SEK 2mSEK 1m

SEK 175m

Sep 30 2020n/an/a

SEK 149m

Jun 30 2020n/an/a

SEK 179m

Mar 31 2020n/an/a

SEK 201m

Dec 31 2019SEK 7mSEK 3m

SEK 187m

Sep 30 2019n/an/a

SEK 196m

Jun 30 2019n/an/a

SEK 173m

Mar 31 2019n/an/a

SEK 170m

Dec 31 2018SEK 7mSEK 3m

SEK 168m

Sep 30 2018n/an/a

SEK 175m

Jun 30 2018n/an/a

SEK 162m

Mar 31 2018n/an/a

SEK 148m

Dec 31 2017SEK 6mSEK 3m

SEK 139m

보상 대 시장: Torben 의 총 보상 ($USD 82.12K ) Swedish 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 776.13K ).

보상과 수익: Torben 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Torben Jorgensen (72 yo)

less than a year

테뉴어

SEK 857,000

보상

Mr. Torben Jorgensen, B.Sc. serves as President at Biotage AB form January 04, 2024 and serves as its as CEO since 2024 and served as its as Interim CEO since January 04, 2024 until 2024 and served as its...

리더십 팀

이름위치테뉴어보상소유권
Torben Jorgensen
CEO, President & Directorless than a yearSEK 857.00k0.40%
SEK 50.8m
Andrew Kellett
Chief Financial Officerless than a year데이터 없음데이터 없음
Anders Wikstrom
Executive Vice President of Operations14.2yrs데이터 없음0.0064%
SEK 817.0k
Raffaella Bombarda
EVP of Global Marketingno data데이터 없음데이터 없음
Petra Duprez
Chief Human Resources & Sustainability Officerno data데이터 없음0.019%
SEK 2.4m
Scott Carr
President of Americas & Chief/Head of Americasno data데이터 없음0.0064%
SEK 817.0k
Jonas Stahlberg
Chief Auditorno data데이터 없음데이터 없음
Olof Nord
Executive Vice President of Business Developmentno data데이터 없음0.025%
SEK 3.2m
Andreas Juhlin
President of International - EMEA and APAC4.1yrs데이터 없음0.0064%
SEK 817.0k
Magnus Nordstedt
Executive Vice President of IT & Digitalizationno data데이터 없음0.0059%
SEK 744.5k
Lisa Egelrud
Executive Vice President of Quality Assurance & Regulatory Affairs3.5yrs데이터 없음데이터 없음
Maryam Poorafshar
Executive Vice President R&Dno data데이터 없음데이터 없음

3.5yrs

평균 재임 기간

52.5yo

평균 연령

경험이 풍부한 관리: BIOT 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Torben Jorgensen
CEO, President & Director4.7yrsSEK 857.00k0.40%
SEK 50.8m
Kieran Murphy
Chairman1.3yrsSEK 227.00k데이터 없음
Peter von Ehrenheim
Director11.3yrsSEK 407.00k0.020%
SEK 2.5m
Asa Hedin
Director4.7yrsSEK 337.00k데이터 없음
Mark Bradley
Director5.3yrsSEK 307.00k데이터 없음
Kugan Sathiyanandarajah
Director1.3yrs데이터 없음데이터 없음
Dan Menasco
Employee Representative Director2.6yrs데이터 없음데이터 없음
Karen Soerensen
Director2.3yrsSEK 357.00k데이터 없음
Par Lundgren
Employee Representative Directorno data데이터 없음데이터 없음
Philip Lamberstam
Employee Representative Directorless than a year데이터 없음데이터 없음

2.6yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: BIOT 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.